Navidea Biopharmaceuticals Announces $4.2 Million Sale of Ohio Court Judgment and $3.4 Million Equity Raise Representing $7.6 Million in Additional Funding
Amount Raised
$4 Million
Round Type
Seed
DublinBiotechnologyHealth CareDescription
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that they have executed agreements with two existing investors, including John K. Scott, Jr. (collectively, the “Investors”), to purchase approximately 4.0 million shares of the Company’s common stock, par value $0.001 per share, for aggregate gross proceeds to Navidea of approximately $3.4 million
Quick answer
Navidea Biopharmaceuticals raised $4 Million in a Seed round, dated February 14, 2020. Navidea Biopharmaceuticals is based in Dublin, California, United States.
- How much did Navidea Biopharmaceuticals raise?
- Navidea Biopharmaceuticals raised $4 Million in a Seed round on February 14, 2020.
- What does Navidea Biopharmaceuticals do?
- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics.
- Where is Navidea Biopharmaceuticals based and how big is it?
- Navidea Biopharmaceuticals is based in Dublin, California, United States.
- Who are the decision-makers at Navidea Biopharmaceuticals?
- Fundz holds 1 contact at Navidea Biopharmaceuticals, including the Senior Vice President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Navidea Biopharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- CytoDyn raised $882K (Seed) on March 30, 2020.
- Medicenna raised $6.7M on March 30, 2020.
- Monteris Medical raised $2.5M (Seed) on March 30, 2020.
- AseptiScope, Inc. raised $230K (Seed) on March 27, 2020.
- Olema Pharmaceuticals, Inc. raised $30M on March 27, 2020.
- Affinia Therapeutics raised $39M on March 27, 2020.
Who to call at Navidea Biopharmaceuticals, and when
A new round usually means Navidea Biopharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Navidea Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Navidea Biopharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Navidea Biopharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Navidea Biopharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Navidea Biopharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.